case_images: PMC7425316_01
case_images: (a) Preoperative lateral and (b) posterior views of keloid with ulceration and necrosis.
case_images: 10.1177_2050313X20936033-fig1.jpg
case_images: PMC7425316_01_10.1177_2050313X20936033-fig1.jpg
case_images: fig1-2050313X20936033
case_images: He suffered from significant decreased quality of life due to social stigma, pain, ulceration from minor trauma, infection, and restriction in lateral neck rotation and flexion (Figure 1(a) and (b)).
case_images: Keloid prior to fractional laser-assisted delivery of topical TAC.
case_images: 10.1177_2050313X20936033-fig2.jpg
case_images: PMC7425316_01_10.1177_2050313X20936033-fig2.jpg
case_images: fig2-2050313X20936033
case_images: He also had restriction in lateral movement of his neck, and his wound was firm to palpation (Figure 2).
case_images: Keloid scar following six fractional laser-assisted topical TAC treatments.
case_images: 10.1177_2050313X20936033-fig3.jpg
case_images: PMC7425316_01_10.1177_2050313X20936033-fig3.jpg
case_images: fig3-2050313X20936033
case_images: The patient suffered from no further ulceration of the skin during this fractional laser-assisted drug delivery. The patient remains pleased with the functional and cosmetic appearance of his scar 22 months from his last such treatment and has not had recurrence of the keloid 47 months from his excision (Figure 3).